IsovitexinCAS# 38953-85-4 |
Package In Stock
- IsovitexinApigenin6-C-glucoside
Catalog No.:BCX0887
CAS No.:29702-25-8
Quality Control & MSDS
Chemical structure
3D structure
Number of papers citing our products
Cas No. | 38953-85-4 | SDF | Download SDF |
PubChem ID | 162350 | Appearance | Yellow powder |
Formula | C21H20O10 | M.Wt | 432.4 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Synonyms | Saponaretin; Homovitexin; 29702-25-8; 6-Glucosylapigenin; Apigenin-6-C-Glucoside; 6-C-Glucosylapigenin | ||
Solubility | DMSO : ≥ 86.6 mg/mL (200.29 mM) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one | ||
SMILES | C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C=C3O2)O)C4C(C(C(C(O4)CO)O)O)O)O)O | ||
Standard InChIKey | MYXNWGACZJSMBT-VJXVFPJBSA-N | ||
Standard InChI | InChI=1S/C21H20O10/c22-7-14-17(26)19(28)20(29)21(31-14)16-11(25)6-13-15(18(16)27)10(24)5-12(30-13)8-1-3-9(23)4-2-8/h1-6,14,17,19-23,25-29H,7H2/t14-,17-,19+,20-,21+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Isovitexin, a food phytochemical contained in dietary rice products, it exhibits in vivo α-glucosidase inhibition, it possesses antihyperglycemic, neuroprotective, anti-inflammatory and anti-oxidant activities. Isovitexin inhibited xanthine oxidase with an IC50 value of 15.2 microM, it may protect cells from oxidative stress. It inhibited JNK, MAPK and NF-κB and activated HO-1/Nrf2 pathways. |
Targets | NF-kB | IkB | ROS | NO | NOS | COX | HO-1 | Nrf2 | MAPK | IKK | JNK |
In vitro | Passiflora actinia hydroalcoholic extract and its major constituent, isovitexin, are neuroprotective against glutamate-induced cell damage in mice hippocampal slices.[Pubmed: 26800497]J Pharm Pharmacol. 2016 Feb;68(2):282-91.To investigate whether Passiflora actinia hydroalcoholic extract and its major constituent, Isovitexin, protect mice hippocampal brain slices from glutamate-induced neurotoxicity.
Isovitexin suppresses lipopolysaccharide-mediated inducible nitric oxide synthase through inhibition of NF-kappa B in mouse macrophages.[Pubmed: 16142640]Planta Med. 2005 Aug;71(8):748-53.Isovitexin exhibits potent antioxidant activities.
In this study, the activity of nitric oxide synthase (iNOS) in lipopolysaccharide (LPS)-activated RAW264.7 macrophages after incubation with Isovitexin was investigated.
|
In vivo | Vitexin and isovitexin from the Leaves of Ficus deltoidea with in-vivo α-glucosidase inhibition.[Pubmed: 22683902]J Ethnopharmacol. 2012 Aug 1;142(3):776-81.The leaves of Ficus deltoidea are used as a traditional medicine by diabetes patients in Malaysia.
The objective of the study is to identify and evaluate bioactive constituents with in vivo α-glucosidase inhibition.
|
Cell Research | Prevention of cellular ROS damage by isovitexin and related flavonoids.[Pubmed: 11988866 ]Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-κB and Activating HO-1/Nrf2 Pathways.[Pubmed: 26722219]Int J Biol Sci. 2016 Jan 1;12(1):72-86.Oxidative damage and inflammation are closely associated with the pathogenesis of acute lung injury (ALI). Thus, we explored the protective effect of Isovitexin (IV), a glycosylflavonoid, in the context of ALI.
Planta Med. 2002 Apr;68(4):365-7.The antioxidant properties of Isovitexin and related flavonoids were studied.
|
Structure Identification | J Agric Food Chem. 2012 Oct 31;60(43):10844-9.Enzymatic acylation of isoorientin and isovitexin from bamboo-leaf extracts with fatty acids and antiradical activity of the acylated derivatives.[Pubmed: 23057589]
|
Isovitexin Dilution Calculator
Isovitexin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.3127 mL | 11.5634 mL | 23.1267 mL | 46.2535 mL | 57.8168 mL |
5 mM | 0.4625 mL | 2.3127 mL | 4.6253 mL | 9.2507 mL | 11.5634 mL |
10 mM | 0.2313 mL | 1.1563 mL | 2.3127 mL | 4.6253 mL | 5.7817 mL |
50 mM | 0.0463 mL | 0.2313 mL | 0.4625 mL | 0.9251 mL | 1.1563 mL |
100 mM | 0.0231 mL | 0.1156 mL | 0.2313 mL | 0.4625 mL | 0.5782 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Vitexin 4'-glucoside
Catalog No.:BCC9252
CAS No.:38950-94-6
- Chelerythrine chloride
Catalog No.:BCN8322
CAS No.:3895-92-9
- SBHA
Catalog No.:BCC2425
CAS No.:38937-66-5
- Isodeoxyelephantopin
Catalog No.:BCN4638
CAS No.:38927-54-7
- erythro-Guaiacylglycerol
Catalog No.:BCN5440
CAS No.:38916-91-5
- Halaminol C
Catalog No.:BCN1787
CAS No.:389125-68-2
- Halaminol B
Catalog No.:BCN1748
CAS No.:389125-59-1
- Halaminol A
Catalog No.:BCN1788
CAS No.:389125-56-8
- Z-Glu(OtBu)-OH
Catalog No.:BCC2776
CAS No.:3886-08-6
- CK 869
Catalog No.:BCC6347
CAS No.:388592-44-7
- PSN 375963 hydrochloride
Catalog No.:BCC7663
CAS No.:388575-52-8
- Tetrahydroepiberberine
Catalog No.:BCN2649
CAS No.:38853-67-7
- Icariside D2
Catalog No.:BCN7217
CAS No.:38954-02-8
- Piperlotine A
Catalog No.:BCN6481
CAS No.:389572-70-7
- Prasugrel hydrochloride
Catalog No.:BCC4291
CAS No.:389574-19-0
- Prasugrel Maleic acid
Catalog No.:BCC4292
CAS No.:389574-20-3
- Raspberry ketone glucoside
Catalog No.:BCC8244
CAS No.:38963-94-9
- N-Acetylnorloline
Catalog No.:BCN2005
CAS No.:38964-35-1
- Eriodictyol-7-O-glucoside
Catalog No.:BCN4743
CAS No.:38965-51-4
- 2'-O-Methylperlatolic acid
Catalog No.:BCN5442
CAS No.:38968-07-9
- Ophiopogonin B
Catalog No.:BCN5378
CAS No.:38971-41-4
- α-Tocopherol phosphate
Catalog No.:BCC5420
CAS No.:38976-17-9
- (S)-CPW 399
Catalog No.:BCC7106
CAS No.:389888-02-2
- Gelsevirine
Catalog No.:BCN5443
CAS No.:38990-03-3
Potential insulin secretagogue effects of isovitexin and swertisin isolated from Wilbrandia ebracteata roots in non-diabetic rats.[Pubmed:20678557]
Fitoterapia. 2010 Dec;81(8):1180-7.
The antihyperglycemic effect and mechanism of action of extracts, fractions and compounds from Wilbrandia ebracteata was studied. The crude extract reduced the glycemia, increased glycogen content and serum insulin in hyperglycemic rats. Also, a significant effect was observed with the n-butanol and metanol subfraction. However, the antihyperglycemic effect of the n-butanol fraction was not observed in diabetic rats. The C-glycosylflavones Isovitexin and swertisin showed a strong antihyperglycemic action compared with the extracts and fractions. These results show that the extracts, fractions, and isolated C-glycosylflavones have an antihyperglycemic action that was reinforced by the stimulation on in vivo insulin secretion.
Isovitexin suppresses lipopolysaccharide-mediated inducible nitric oxide synthase through inhibition of NF-kappa B in mouse macrophages.[Pubmed:16142640]
Planta Med. 2005 Aug;71(8):748-53.
Isovitexin exhibits potent antioxidant activities. In this study, the activity of nitric oxide synthase (iNOS) in lipopolysaccharide (LPS)-activated RAW264.7 macrophages after incubation with Isovitexin was investigated. Isovitexin was able to reduce the production of hydrogen peroxide induced by LPS in mouse macrophage RAW264.7 cells. The cells incubated with Isovitexin had markedly reduced LPS-stimulated NO production with an IC (50) value of 58.5 microM. The expression of iNOS was also inhibited when the cells were treated with Isovitexin. A transient transfection experiment showed that Isovitexin suppressed the iNOS promoter and NF-kappaB-dependent transcriptional activities. It was also found to inhibit IKK kinase activity and prevent the degradation of IkappaBalpha in activated RAW264.7 cells. Additionally, Western blotting analysis revealed that Isovitexin prevented the translocation of NF-kappaB from the cytoplasm to the nucleus. Our results indicate that its ROS scavenger and IKK inhibitory activities also contribute to the suppression of ROS-mediated NF-kappaB activity. These results suggest that Isovitexin, a food phytochemical contained in dietary rice products, might have biological significance.
Prevention of cellular ROS damage by isovitexin and related flavonoids.[Pubmed:11988866]
Planta Med. 2002 Apr;68(4):365-7.
The antioxidant properties of Isovitexin and related flavonoids were studied. Isovitexin inhibited xanthine oxidase with an IC50 value of = 15.2 microM. The flavonoid analogues, apigenin, kaempferol, quercetin, myricetin, and genistein also inhibited xanthine oxidase with IC50 values of 0.58, 2.18, 1.09, 9.90, and 4.83 microM, respectively. Isovitexin protected DNA from the Fenton reaction-induced breakage in a dose-dependent manner with an IC50 value of 9.52 microM. Isovitexin also protected HL-60 cells from the ROS damage induced by the xanthine/xanthine oxidase reaction. Isovitexin exhibited the lowest cytotoxicity toward HL-60 cells (LD50 >400 microM) compared to the other flavonoids examined. In addition, excess hydrogen peroxide induced by cadmium in A2780 ovarian cells was significantly suppressed by Isovitexin. These results suggest that Isovitexin in rice may protect cells from oxidative stress.
Enzymatic acylation of isoorientin and isovitexin from bamboo-leaf extracts with fatty acids and antiradical activity of the acylated derivatives.[Pubmed:23057589]
J Agric Food Chem. 2012 Oct 31;60(43):10844-9.
This study enzymatically acrylates two flavonoids from bamboo-leaf extracts, isoorientin and Isovitexin, with different fatty acids as acyl donors using Candida antarctica lipase B (CALB). The conversion yield ranged from 35 to 80% for fatty acids with different chain lengths. Higher isoorientin and Isovitexin conversion yields (>75%) were obtained using lauric acid in tert-amyl-alcohol as the reaction medium. (1)H and (13)C nuclear magnetic resonance spectroscopy analysis showed that, in the presence of CALB, acylation occurred at the isoorientin and Isovitexin primary hydroxyl group of glucose moiety and only monoesters were detected. Introducing an acyl group into isoorientin and Isovitexin significantly improved their lipophilicity but reduced their antiradical activity.
Passiflora actinia hydroalcoholic extract and its major constituent, isovitexin, are neuroprotective against glutamate-induced cell damage in mice hippocampal slices.[Pubmed:26800497]
J Pharm Pharmacol. 2016 Feb;68(2):282-91.
OBJECTIVES: To investigate whether Passiflora actinia hydroalcoholic extract and its major constituent, Isovitexin, protect mice hippocampal brain slices from glutamate-induced neurotoxicity. METHODS: Neuroprotective effect of the extract against glutamate-induced excitotoxicity (10 mm) was evaluated through cell viability of hippocampal slices. The extract or its flavonoids were directly applied to hippocampal slices and then subjected to glutamate-induced toxicity. Alternatively, hippocampal slices from extract-treated mice were also subjected to the same toxicity protocol. KEY FINDINGS: Mice supplementation with the extract protected hippocampal slices from in-vitro neurotoxicity. When directly applied to hippocampal slices, the extract showed a higher neuroprotective potential than a commercial dry extract of Passiflora incarnata, which was related to P. actinia extract which had higher Isovitexin and total flavonoid content expressed as Isovitexin. Isovitexin, but not apigenin, induced a similar neuroprotective response when applied alone, at a concentration equivalent to that found in the extract. CONCLUSIONS: This study highlights new neuropharmacological activity of the Passiflora genus, suggesting that it can act as modulator of the glutamatergic system. The search for improved pharmacotherapies with novel mechanisms of action has been shown of great importance for the treatment of resistant neurological and psychiatric disorders.
Vitexin and isovitexin from the Leaves of Ficus deltoidea with in-vivo alpha-glucosidase inhibition.[Pubmed:22683902]
J Ethnopharmacol. 2012 Aug 1;142(3):776-81.
ETHNOPHARMACOLOGICAL RELEVANCE: The leaves of Ficus deltoidea are used as a traditional medicine by diabetes patients in Malaysia. AIM OF THE STUDY: The objective of the study is to identify and evaluate bioactive constituents with in vivo alpha-glucosidase inhibition. MATERIALS AND METHODS: The partitioned extracts, subfractions and pure bioactive constituents were subjected to alpha-glucosidase inhibition assay. The identified bioactive constituents were administered orally to sucrose loaded normoglycemic mice and induced diabetic rats. The postprandial blood glucose levels were monitored at 30 min interval. Acute toxicity was evaluated in both normoglycemic mice and induced diabetic rats. RESULTS: Bioactivity guided fractionation led to the isolation of both vitexin (1) and Isovitexin (2). Oral administration of 1mg/kg of either vitexin (1) or Isovitexin (2) significantly (p<0.05) reduced the postprandial blood glucose level in sucrose loaded normoglycemic mice at 30 min. The percentage of postprandial blood glucose reduction was highest in sucrose loaded induced diabetic rats administered orally with 200mg/kg of vitexin (1) or 100mg/kg of Isovitexin (2). Both vitexin (1) and Isovitexin (2) did not exert any signs of toxicity at the highest dose of 2g/kg administered orally to normoglycemic mice and induced diabetic rats. CONCLUSION: Both the C-glycosyl bioflavonoids, namely, vitexin (1) and Isovitexin (2) exhibited in vivo alpha-glucosidase inhibition.
Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-kappaB and Activating HO-1/Nrf2 Pathways.[Pubmed:26722219]
Int J Biol Sci. 2016 Jan 1;12(1):72-86.
Oxidative damage and inflammation are closely associated with the pathogenesis of acute lung injury (ALI). Thus, we explored the protective effect of Isovitexin (IV), a glycosylflavonoid, in the context of ALI. To accomplish this, we created in vitro and in vivo models by respectively exposing macrophages to lipopolysaccharide (LPS) and using LPS to induce ALI in mice. In vitro, our results showed that IV treatment reduced LPS-induced pro-inflammatory cytokine secretion, iNOS and COX-2 expression and decreased the generation of ROS. Consistent findings were obtained in vivo. Additionally, IV inhibited H2O2-induced cytotoxicity and apoptosis. However, these effects were partially reversed following the use of an HO-1 inhibitor in vitro. Further studies revealed that IV significantly inhibited MAPK phosphorylation, reduced NF-kappaB nuclear translocation, and upregulated nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase 1 (HO-1) expression in RAW 264.7 cells. In vivo, pretreatment with IV attenuated histopathological changes, infiltration of polymorphonuclear granulocytes and endothelial activation, decreased the expression of ICAM-1 and VCAM-1, reduced the levels of MPO and MDA, and increased the content of GSH and SOD in ALI. Furthermore, IV treatment effectively increased Nrf2 and HO-1 expression in lung tissues. Therefore, IV may offer a protective role against LPS-induced ALI by inhibiting MAPK and NF-kappaB and activating HO-1/Nrf2 pathways.